BASF sells Norwegian omega-3 business to US firm

By Shane STARLING

- Last updated on GMT

BASF sells Norwegian omega-3 business to US firm

Related tags Omega-3 fatty acids Nutrition

BASF has sold its Norwegian, “natural fish oils, medium-concentrated omega-3s, and customised bottled fish oil” plant to Pennsylvania firm Marine Ingredients for an undisclosed sum as the German ingredients and chemicals giant switches its focus to high-end omega-3s.

It said the move was about it focusing on its recent high-end omega-3 acquisitions of Scottish firm Equateq in 2012, (now BASF Pharma Callanish (undisclosed)) and Norwegian high-end plyer Pronova Biopharma in 2013 (€684m).

“Highly concentrated omega-3 fatty acids for consumer health, clinical nutrition and pharmaceutical products are one of the key growth areas for BASF’s Nutrition & Health division,”​ the company said in a statement.

Although the omega-3 segment has hit some headwinds​ in markets such as the US due to the publication of studies that questioned its health benefits, the segment is worth upwards of €20bn globally in supplements, foods and pharma products and still growing on a global level.

BASF said: “Thanks to increased awareness of its health benefits, omega-3 has become an increasingly important segment of the dietary supplement, functional food and pharmaceuticals market. Several thousand academic and clinical studies have investigated the potential health benefits of omega-3 fatty acids. Most of these studies identified omega-3 as beneficial for human health and highlighted its cardiovascular benefits.”

The company was unavailable for further comment at the time of publication.

Marine Ingredients specialises in omega-3 softgel and liquid formulations.

Related news

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers

F&B Trailblazers Podcast